Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World

PURPOSE: To compare the efficacy, safety, and cost-effectiveness of methotrexate (MTX) plus hydroxychloroquine (HCQ) vs MTX plus leflunomide (LEF) in established rheumatoid arthritis (RA) with inadequate response to MTX monotherapy in a real-world Chinese cohort. PATIENTS AND METHODS: A prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Le, Chen, Fangfang, Geng, Shikai, Wang, Xiaodong, Gu, Liyang, Lang, Yitian, Li, Ting, Ye, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755368/
https://www.ncbi.nlm.nih.gov/pubmed/33376379
http://dx.doi.org/10.2147/JIR.S282249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755368/
https://www.ncbi.nlm.nih.gov/pubmed/33376379
http://dx.doi.org/10.2147/JIR.S282249

Ejemplares similares